Literature DB >> 9759754

Thrombotic thrombocytopenic purpura after stenting and ticlopidine.

C L Bennett, J E Kiss, P D Weinberg, A J Pinevich, D Green, H C Kwaan, M D Feldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9759754     DOI： 10.1016/s0140-6736(05)60079-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Drug-induced thrombocytopenia in the coronary care unit.

Authors:  N M Patnode; P J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 2.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Drug-related deaths: an analysis of the Italian spontaneous reporting database.

Authors:  Roberto Leone; Laura Sottosanti; Maria Luisa Iorio; Carmela Santuccio; Anita Conforti; Vilma Sabatini; Ugo Moretti; Mauro Venegoni
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.

Authors:  Jesse Weinberger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  [Ticlopidine-associated thrombotic thrombocytopenic purpura (Morbus Moschcowitz)].

Authors:  J Carlsson; S Miketic; R Bätge; P Riedel; G Rahlf; U Tebbe
Journal:  Med Klin (Munich)       Date:  2000-01-15

6.  Antithrombotic Secondary Prevention After Stroke.

Authors:  Hans-Christoph Diener; Peter Ringleb
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.598

7.  Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; L Rice; R Sarode; T W Chow; J L Moake
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

Review 8.  Clopidogrel and coronary stenting: what is the next question?

Authors:  S A Moore; S R Steinhubl
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 9.  Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).

Authors:  Anaadriana Zakarija; Hau C Kwaan; Joel L Moake; Nicholas Bandarenko; Dilip K Pandey; June M McKoy; Paul R Yarnold; Dennis W Raisch; Jeffrey L Winters; Thomas J Raife; John F Cursio; Thanh Ha Luu; Elizabeth A Richey; Matthew J Fisher; Thomas L Ortel; Martin S Tallman; X Long Zheng; Masanori Matsumoto; Yoshihiro Fujimura; Charles L Bennett
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

Review 10.  Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  June M McKoy; Matthew J Fisher; D Mark Courtney; Dennis W Raisch; Beatrice J Edwards; Marc H Scheetz; Steven M Belknap; Steven M Trifilio; Athena T Samaras; Dustin B Liebling; Beatrice Nardone; Katrina Marie Tulas; Dennis P West
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.